President Trump signed an executive order last week to modernize kidney-disease treatment for the first time in decades, a move that could reduce spending and improve treatment for one of the country's most pervasive illnesses. Citing the many millions of Americans suffering chronic kidney disease and kidney failure, the EO required Medicare to test different payment models encouraging a range of options that will improve patients’ lives and maybe even save some money.